HC Surgical Specialists Ltd
SGX:1B1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HC Surgical Specialists Ltd
SGX:1B1
|
SG |
|
A
|
Aegis Logistics Ltd
NSE:AEGISCHEM
|
IN |
|
KIYO Learning Co Ltd
TSE:7353
|
JP |
|
Verite Co Ltd
TSE:9904
|
JP |
Balance Sheet
Balance Sheet Decomposition
HC Surgical Specialists Ltd
HC Surgical Specialists Ltd
Balance Sheet
HC Surgical Specialists Ltd
| May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
6
|
9
|
5
|
5
|
7
|
11
|
7
|
6
|
7
|
5
|
|
| Cash |
1
|
1
|
5
|
4
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
1
|
5
|
0
|
1
|
7
|
11
|
7
|
6
|
7
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
2
|
2
|
1
|
3
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
1
|
3
|
2
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
2
|
1
|
7
|
10
|
7
|
8
|
9
|
14
|
9
|
13
|
11
|
8
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
1
|
1
|
4
|
5
|
4
|
4
|
4
|
4
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
4
|
3
|
3
|
3
|
|
| Goodwill |
0
|
0
|
0
|
3
|
5
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
9
|
11
|
10
|
11
|
13
|
9
|
9
|
10
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Other Assets |
0
|
0
|
0
|
3
|
5
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-11%
|
7
+301%
|
16
+117%
|
23
+45%
|
27
+18%
|
30
+14%
|
36
+19%
|
31
-15%
|
31
+1%
|
28
-11%
|
27
-2%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
8
|
6
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
|
| Other Current Liabilities |
0
|
1
|
4
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
|
| Total Current Liabilities |
1
|
1
|
5
|
2
|
5
|
5
|
4
|
8
|
8
|
11
|
11
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
7
|
6
|
4
|
3
|
2
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
12
|
8
|
4
|
1
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+38%
|
5
+261%
|
2
-65%
|
6
+241%
|
7
+14%
|
14
+110%
|
26
+87%
|
20
-25%
|
19
-4%
|
13
-31%
|
6
-52%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
13
|
14
|
14
|
15
|
15
|
15
|
15
|
17
|
17
|
|
| Retained Earnings |
1
|
0
|
2
|
1
|
3
|
6
|
1
|
5
|
3
|
2
|
2
|
5
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
1
N/A
|
0
-60%
|
2
+437%
|
14
+543%
|
17
+21%
|
20
+19%
|
16
-18%
|
10
-40%
|
11
+12%
|
12
+10%
|
15
+21%
|
21
+43%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-11%
|
7
+301%
|
16
+117%
|
23
+45%
|
27
+18%
|
30
+14%
|
36
+19%
|
31
-15%
|
31
+1%
|
28
-11%
|
27
-2%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
146
|
146
|
146
|
147
|
149
|
149
|
151
|
149
|
149
|
149
|
154
|
153
|
|